Patterns of treatment failure--implications for new treatment approaches.
Tattersall
M H
MH
Department of Cancer Medicine, University of Sydney, New South Wales.
D000277:Adjuvants, Pharmaceutic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D015337:Multicenter Studies as Topic; D009362:Neoplasm Metastasis; D010052:Ovariectomy; D016032:Randomized Controlled Trials as Topic; D013629:Tamoxifen / Q000627:therapeutic use
D000277:Adjuvants, Pharmaceutic; D013629:Tamoxifen; D004317:Doxorubicin; D003520:Cyclophosphamide